Androgens are thought to play a role in the pathogenesis of prostate cancer. We evaluated androgen levels in 3 age-matched groups of men who were part of the Baltimore Longitudinal Study of Aging: 1) 16 men with no prostatic disease by urologic history and exam (control group); 2) 20 men with a histologic diagnosis of […]
Continue reading →A study of 930 men with coronary heart disease (CHD) showed that those who had testosterone deficiency were at increased risk of death. The overall prevalence of biochemical testosterone deficiency in the study population was 20.9% using a level of bioavailable testosterone levels below 2.6 nmol/L, 16.9% using a total testosterone level below 8.1 nmol/L, and 24% […]
Continue reading →Testosterone replacement therapy and prostate risks: where’s the beef? It has been part of the conventional medical wisdom for six decades that higher testosterone in some way increases the risk of prostate cancer. This belief is derived largely from the well-documented regression of prostate cancer in the face of surgical or pharmacological castration. However, there […]
Continue reading →Assessing progress in our understanding of prostate cancer etiology is difficult, although it is certainly clear that we have much to learn. Despite a substantial research investment spanning dozens of years, prostate cancer remains as enigmatic as it is burdensome. We know that increasing age, African American race, residence in a Western nation, and family […]
Continue reading →Aging has been a fact of life ever since it was created. Human beings go through various phases of life from being child to youth to being adult with youth being the best part of life from health point of view. Good health, strong muscles, an efficient immune system, a sharp memory and a […]
Continue reading →